Cash Cash Equivalents - Immunoprecise Antibodies Ltd (XTSX:IPA) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 6.5 CAD 0.78%

Updated:

Immunoprecise Antibodies Ltd
Cash & Cash Equivalents

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Immunoprecise Antibodies Ltd
Cash & Cash Equivalents Peer Comparison

ABCL

ARCH

RP

IOT

Company		Cash & Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Immunoprecise Antibodies Ltd XTSX:IPA	Cash & Cash Equivalents CA$41.8m	CAGR 3-Years 185%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Abcellera Biologics Inc NASDAQ:ABCL	Cash & Cash Equivalents $133.3m	CAGR 3-Years -39%	CAGR 5-Years 67%	CAGR 10-Years N/A
	Arch Biopartners Inc XTSX:ARCH	Cash & Cash Equivalents CA$302.6k	CAGR 3-Years -20%	CAGR 5-Years 4%	CAGR 10-Years N/A
	Replicel Life Sciences Inc XTSX:RP	Cash & Cash Equivalents CA$15.2k	CAGR 3-Years -32%	CAGR 5-Years -9%	CAGR 10-Years -41%
	Innovotech Inc XTSX:IOT	Cash & Cash Equivalents CA$160.5k	CAGR 3-Years -33%	CAGR 5-Years 41%	CAGR 10-Years 15%

See Also

Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Cash & Cash Equivalents amounts to 41.8m CAD.

Over the last year, the Cash & Cash Equivalents growth was 1 500%. The average annual Cash & Cash Equivalents growth rates for Immunoprecise Antibodies Ltd have been 185% over the past three years .

Join more than 139,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.